735 related articles for article (PubMed ID: 29321311)
1. Herpes Simplex Virus 1 Mutant with Point Mutations in
Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
3. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
4. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
5. Herpes Simplex Virus 1 Strains 17
Grams TR; Edwards TG; Bloom DC
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461310
[TBL] [Abstract][Full Text] [Related]
6. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.
Pan D; Pesola JM; Li G; McCarron S; Coen DM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847363
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.
Wang H; Davido DJ; Mostafa HH; Morrison LA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632611
[TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
9. Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation.
Davido DJ; Leib DA
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1853-63. PubMed ID: 8760437
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency.
Balliet JW; Schaffer PA
J Virol; 2006 Jan; 80(1):440-50. PubMed ID: 16352568
[TBL] [Abstract][Full Text] [Related]
11. Antagonizing the Glucocorticoid Receptor Impairs Explant-Induced Reactivation in Mice Latently Infected with Herpes Simplex Virus 1.
Harrison KS; Zhu L; Thunuguntla P; Jones C
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971470
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.
Smith TJ; Ackland-Berglund CE; Leib DA
J Virol; 2000 Apr; 74(8):3598-604. PubMed ID: 10729135
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.
Balliet JW; Kushnir AS; Schaffer PA
Virology; 2007 May; 361(2):372-83. PubMed ID: 17207829
[TBL] [Abstract][Full Text] [Related]
14. Herpes Simplex Virus 2 Latency-Associated Transcript (LAT) Region Mutations Do Not Identify a Role for LAT-Associated MicroRNAs in Viral Reactivation in Guinea Pig Genital Models.
Kawamura Y; Bosch-Marce M; Tang S; Patel A; Krause PR
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720520
[TBL] [Abstract][Full Text] [Related]
15. Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.
Matundan HH; Mott KR; Allen SJ; Wang S; Bresee CJ; Ghiasi YN; Town T; Wechsler SL; Ghiasi H
J Virol; 2016 Oct; 90(20):9533-42. PubMed ID: 27512072
[TBL] [Abstract][Full Text] [Related]
16. A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.
Jiang X; Brown D; Osorio N; Hsiang C; Li L; Chan L; BenMohamed L; Wechsler SL
J Neurovirol; 2015 Apr; 21(2):199-209. PubMed ID: 25645379
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.
Mostafa HH; Thompson TW; Kushnir AS; Haenchen SD; Bayless AM; Hilliard JG; Link MA; Pitcher LA; Loveday E; Schaffer PA; Davido DJ
J Virol; 2011 Dec; 85(23):12631-7. PubMed ID: 21937654
[TBL] [Abstract][Full Text] [Related]
18. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
[TBL] [Abstract][Full Text] [Related]
19. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
[TBL] [Abstract][Full Text] [Related]
20. Differential importance of highly conserved residues in UL24 for herpes simplex virus 1 replication in vivo and reactivation.
Leiva-Torres GA; Rochette PA; Pearson A
J Gen Virol; 2010 May; 91(Pt 5):1109-16. PubMed ID: 20071482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
